Serine auxotrophy is a targetable vulnerability driven by PSAT1 suppression in AML
- DOI
- 10.1101/2025.05.13.651470
- Published
- 2025-05-14
- Container
- Not recorded
- Publisher
- openRxiv
- Open access
- unknown
Credibility signals
uncertain Score 60/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- cautionPublication version: Identified as a preprint; peer review and later versions may change the record.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1101/2025.05.13.651470,
title = {Serine auxotrophy is a targetable vulnerability driven by PSAT1 suppression in AML},
author = {Ilias Sinanidis and Panagiotis Tsakiroglou and Benjamin Dubner and Rebecca Foertsch and Julia Gondek and InYoung Choi and Bogdan Paun and Liang Zhao and Gabriel Ghiaur and W. Brian Dalton},
year = {2025},
doi = {10.1101/2025.05.13.651470},
url = {https://doi.org/10.1101/2025.05.13.651470}
}RIS
TY - JOUR TI - Serine auxotrophy is a targetable vulnerability driven by PSAT1 suppression in AML AU - Ilias Sinanidis AU - Panagiotis Tsakiroglou AU - Benjamin Dubner AU - Rebecca Foertsch AU - Julia Gondek AU - InYoung Choi AU - Bogdan Paun AU - Liang Zhao AU - Gabriel Ghiaur AU - W. Brian Dalton PY - 2025 DO - 10.1101/2025.05.13.651470 UR - https://doi.org/10.1101/2025.05.13.651470 ER -
APA
Sinanidis, I., Tsakiroglou, P., Dubner, B., Foertsch, R., Gondek, J., Choi, I., Paun, B., Zhao, L., Ghiaur, G., & Dalton, W. B. (2025). Serine auxotrophy is a targetable vulnerability driven by PSAT1 suppression in AML. https://doi.org/10.1101/2025.05.13.651470
Source records
- crossref · retrieved 2026-09-26T19:39:17.147Z